Argent BioPharma Limited (ASX:RGT)
Australia · Delayed Price · Currency is AUD 0.1300
-0.0100 (-7.14%)
Last updated: Aug 27, 2025
Argent BioPharma Market Cap
Argent BioPharma has a market cap or net worth of 9.74 million as of August 29, 2025. Its market cap has decreased by -29.36% in one year.
Market Cap
9.74M
Enterprise Value
18.38M
Revenue
295.83K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.13
Market Cap Chart
Since September 28, 2012, Argent BioPharma's market cap has increased from 3.12M to 9.74M, an increase of 212.58%. That is a compound annual growth rate of 9.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 9.38M | 1.71% |
| Dec 31, 2024 | 9.23M | -46.77% |
| Dec 29, 2023 | 17.33M | -45.96% |
| Dec 30, 2022 | 32.07M | -67.88% |
| Dec 31, 2021 | 99.85M | 123.36% |
| Dec 31, 2020 | 44.70M | 1.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 104.45B |
| Pro Medicus | 31.98B |
| Cochlear | 19.73B |
| Sonic Healthcare | 11.89B |
| Ramsay Health Care | 8.75B |
| Telix Pharmaceuticals | 6.23B |
| Ansell | 4.98B |
| Mesoblast | 3.19B |